Early insulin therapy for type 2 diabetic patients: more cost than benefit.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Diabetes Care

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/DIACARE.28.1.222PMID 15616257
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Short-term intensive insulin therapy in newly diagnosed type 2 diabetes.

  2004cited by this paper
• Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function.

  2004cited by this paper
• Short-Term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes

  2004cited by this paper
• The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus.

  2001cited by this paper
• Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)

  2001cited by this paper
• Progression of microalbuminuria to proteinuria in type 1 diabetes: nonlinear relationship with hyperglycemia.

  2000cited by this paper
• Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

  2000cited by this paper
• Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria

  1999cited by this paper
• The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.

  1999cited by this paper
• Is there a glycemic threshold for mortality risk?

  1999cited by this paper
• Glycemic control and cardiovascular disease in Type 2 diabetes: a review

  1999cited by this paper
• Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe.

  1999cited by this paper
• Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men.

  1999cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Role of Glycemic Control and Blood Pressure in the Development and Progression of Nephropathy in Elderly Japanese NIDDM Patients

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Case-control study of sudden infant death syndrome in Scotland, 1992-5

  1997cited by this paper
• Maximal dose glyburide therapy in markedly symptomatic patients with type 2 diabetes: a new use for an old friend.

  1996cited by this paper
• Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction.

  1996cited by this paper
• The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications Trial

  1995cited by this paper
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

  1995cited by this paper
• Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus.

  1995cited by this paper
• U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease

  1995cited by this paper
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus : a randomized prospective 6-year study

  1995cited by this paper
• Feasibility of Insulin-Glucose Infusion in Diabetic Patients With Acute Myocardial Infarction: A report from the multicenter trial: DIGAMI

  1994cited by this paper
• Undiagnosed NIDDM: Clinical and Public Health Issues

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Glucose toxicity.

  1992cited by this paper
• UK Prospective Diabetes Study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors.

  1990cited by this paper
• Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes.

  1988cited by this paper
• The Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes Mellitus

  1985cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• The case for control in diabetes mellitus.

  1978cited by this paper

• The impact of attitudes on medication adherence in patients with type 1 and type 2 diabetes mellitus in Serbia

  2024cites this paper
• The antidiabetic potential of endophytic fungi: Future prospects as therapeutic agents

  2021cites this paper
• Beliefs of Caribbean type 2 diabetes patients towards insulin therapy and prescription

  2020cites this paper
• Factors Affecting Insulin Compliance in Patients with Type 2 Diabetes in South Iran, 2017: We Are Faced with Insulin Phobia

  2019cites this paper
• Should the last be first? Questions and dilemmas regarding early short-term insulin treatment in Type 2 Diabetes Mellitus

  2018cites this paper
• Postprandial Dysmetabolism (Postprandial Hyperglycemia and Hypertriglyceridemia) in Type 2 Diabetes Patients

  2018cites this paper
• Associations Between Immigrant Status and Pharmacological Treatments for Diabetes in U.S. Adults

  2018cites this paper
• Health Outcomes Associated with Initiation of Basal Insulin After 1, 2, or ≥ 3 Oral Antidiabetes Drug(s) Among Managed Care Patients with Type 2 Diabetes

  2015cites this paper
• Achieving glycaemic targets with basal insulin in T2DM by individualizing treatment

  2014cites this paper
• Duration of diabetes and effectiveness of insulin in the management of insulin-naïve Korean patients uncontrolled on oral antidiabetic drugs: a sub-analysis of the MOdaliTy of Insulin treatment eValuation (MOTIV) registry results

  2014cites this paper
• Predictors of achieving HbA1c <7% and no hypoglycaemia 6 months after initiation of biphasic insulin aspart 30 in patients with type 2 diabetes in the IMPROVE study

  2013cites this paper
• Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study

  2012cites this paper
• Initiation of insulin among veterans with type 2 diabetes and sustained elevation of A1c.

  2012cites this paper
• Barriers to diabetes management: patient and provider factors.

  2011cites this paper
• Successes and challenges of insulin therapy for type 2 diabetes in a managed-care setting

  2010cites this paper
• Efficacy of a staged diabetes management programme in achieving glycaemic goal in a low socio‐economic Hispanic population

  2010cites this paper
• Brief report Successes and challenges of insulin therapy for type 2 diabetes in a managed-care setting

  2010cites this paper
• Update on Insulin Management in Type 2 Diabetes

  2009cites this paper
• Early Insulin Treatment in Type 2 Diabetes

  2009cites this paper
• Barriers to insulin starts for type 2 diabetes

  2007cites this paper
• How to start insulin treatment: Earlier or delayed insulin therapy

  2006cites this paper
• COÛT CROISSANT DE L'INSULINOTHÉRAPIE EN BELGIQUE De l'analyse critique de la situation à la recherche de solutions pratiques

  2006cites this paper
• Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study.

  2005cites this paper